Trial Outcomes & Findings for Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women (NCT NCT01518270)

Results Overview

Photographs were taken of the eyelashes. Length was measured in millimeters. Data from both eyes were averaged for each participant for analysis.

Recruitment status

COMPLETED

Target enrollment

179 participants

Primary outcome timeframe

Baseline

Results posted on

2019-05-01

Participant Flow

Participant milestones

Participant milestones
Measure	Healthy Females Participant's eyelashes were photographed at one study visit.
Overall Study STARTED	179
Overall Study COMPLETED	179
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Healthy Females n=179 Participants Participant's eyelashes were photographed at one study visit.
Age, Continuous	40.3 Years FULL_RANGE 10.3 • n=5 Participants
Sex: Female, Male Female	179 Participants n=5 Participants
Sex: Female, Male Male	0 Participants n=5 Participants

PRIMARY outcome

Timeframe: Baseline

Population: All participants with values available.

Photographs were taken of the eyelashes. Length was measured in millimeters. Data from both eyes were averaged for each participant for analysis.

Outcome measures

Outcome measures
Measure	Healthy Females n=177 Participants Participant's eyelashes were photographed at one study visit.
Eyelash Length as Measured by Digital Image Analysis (DIA)	7.33 Millimeters (mm) Full Range 1.15 • Interval 3.99 to 10.1

SECONDARY outcome

Timeframe: Baseline

Population: All participants with values available.

Photographs were taken of the eyelashes. Eyelash thickness/fullness was assessed across both eyes as an average of the 3 preset areas measured in millimeters squared (mm\^2).

Outcome measures

Outcome measures
Measure	Healthy Females n=153 Participants Participant's eyelashes were photographed at one study visit.
Eyelash Thickness as Measured by Digital Image Analysis (DIA)	1.39 Millimeters squared (mm^2) Full Range 0.56 • Interval 0.32 to 3.13

SECONDARY outcome

Timeframe: Baseline

Population: All participants with values available.

Photographs were taken of the Eyelashes. Eyelash darkness (intensity) was measured within the spline (a narrow area approximately 5 pixels wide that bisects the area of interest). Eyelash darkness was measured in both eyes and averaged for analysis using a scale where 0=black and 255=white.

Outcome measures

Outcome measures
Measure	Healthy Females n=154 Participants Participant's eyelashes were photographed at one study visit.
Eyelash Darkness as Measured by Digital Image Analysis (DIA)	122.2 Units on a scale Full Range 14.0 • Interval 64.7 to 162.5

Adverse Events

Healthy Females

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Vice President Medical Affairs,

Allergan, Inc

Phone: 714-246-4500

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.
Publication restrictions are in place

Restriction type: OTHER